Well, let's see if that is the case. Osiris licensed Prochymal to Mesoblast...let's see what that covers. And note Mesoblast bought out Osiris because they lost a patent challenge. I would not assume that other indications are a given.
New video discussion with Mesoblast CEO, page-89
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.040(3.39%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.18 | $1.13 | $1.928M | 1.679M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 54300 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 23731 | 14 |
View Market Depth
| Last trade - 11.15am 17/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |